Suppr超能文献

一名患有16p11.2和16p12.2遗传性共同缺失的儿童出现阵发性运动诱发性运动障碍伴婴儿惊厥:病例报告及文献复习

Paroxysmal Kinesigenic Dyskinesia With Infantile Convulsions in a Child With Inherited Co-deletion of 16p11.2 and 16p12.2: A Case Report and Literature Review.

作者信息

Ding Man, Yin Bo, Liu Yin, Yao Jiajia, Dong Hongjuan

机构信息

Department of Neurology, Renmin Hospital of Wuhan University, Wuhan, CHN.

出版信息

Cureus. 2025 Jul 25;17(7):e88761. doi: 10.7759/cureus.88761. eCollection 2025 Jul.

Abstract

16p11.2 deletion syndrome is a group disorder associated with intellectual impairment, developmental delay, and autism spectrum disorder (ASD). Paroxysmal kinesigenic dyskinesia with infantile convulsions (PKD/IC) is an extremely rare condition. A 6-year-old Chinese boy presented with a two-month history of involuntary dystonic movements triggered by movement initiation (e.g., starting to walk, sudden activity after rest) or occurring spontaneously. He had a history of self-limiting infantile epilepsy from 6 months to 2 years of age. Notably, his father experienced benign infantile epilepsy during infancy (onset at 9 months, duration one year), and his grandparents were consanguineous. Based on clinical manifestations and whole-exome sequencing revealing biallelic inherited deletions, a 661.385 kb deletion at 16p11.2 (encompassing the PRRT2 gene) and a 760.266 kb deletion at 16p12.2 in the proband, with corresponding paternal deletions, the patient was diagnosed with PKD/IC. The patient received oral oxcarbazepine (OXC, 150 mg/day) to improve the symptoms. During follow-up after treatment initiation, his symptoms were well controlled, with no further PKD attacks. Early diagnosis of the disease is highly cost-effective and can help avoid unnecessary diagnostic and therapeutic interventions.

摘要

16p11.2缺失综合征是一种与智力障碍、发育迟缓及自闭症谱系障碍(ASD)相关的群体疾病。伴有婴儿惊厥的发作性运动诱发性运动障碍(PKD/IC)是一种极为罕见的病症。一名6岁中国男孩出现了为期两个月的非自愿性肌张力障碍运动,这些运动由运动起始(如开始行走、休息后突然活动)引发或自发出现。他有6个月至2岁时自限性婴儿癫痫病史。值得注意的是,他的父亲在婴儿期经历过良性婴儿癫痫(9个月发病,持续一年),且他的祖父母是近亲。基于临床表现及全外显子组测序显示的双等位基因遗传性缺失,先证者16p11.2处有一个661.385 kb的缺失(包含PRRT2基因)以及16p12.2处有一个760.266 kb的缺失,且父亲有相应缺失,该患者被诊断为PKD/IC。患者接受口服奥卡西平(OXC,150毫克/天)以改善症状。在开始治疗后的随访期间,他的症状得到良好控制,未再出现PKD发作。该疾病的早期诊断具有很高的成本效益,有助于避免不必要的诊断和治疗干预。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验